The Secretaries of Health, José Narro Robles, and Economy, Ildefonso Guajardo, signed an agreement in June to boost economic growth and strengthen the pharmaceutical sector, along with the production of medical devices. Both ministries recognize national development as a strategic priority. The objective of the declaration is to promote research and increase the export capacity of medicines.
The agreement establishes mechanisms and coordinated actions between the National Chamber of the Pharmaceutical Industry (CANIFARMA), the Mexican Association of Innovative Industries of Medical Devices (AMID) and the State Secretariats. Guillermo Funes Rodríguez (owner of CANIFARMA) and Carlos Jiménez (president of AMID) also signed the document. The objective, according to officials, is to work on new lines of clinical research and take advantage of the contribution of new technologies.
The governor of Jalisco, Aristóteles Sandoval Díaz, pointed out that the introduction of new drugs explains the 40% increase in life expectancy. In this sense, by maximizing the benefits that the sector brings to the national economy, it also impacts the welfare of Mexicans. In recent weeks Andrés Manuel López Obrador (the presidential winner as of Sunday, July 1st) said he agrees with the unification of the health system, which would improve the positive impact of these measures when it comes to preventing diseases and using available resources efficiently.